image
Healthcare - Biotechnology - NASDAQ - CH
$ 47.25
0.854 %
$ 4.03 B
Market Cap
-18.03
P/E
BALANCE SHEET
2.23 B ASSETS
-0.60%
347 M LIABILITIES
-5.66%
1.88 B EQUITY
0.39%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition CRISPR Therapeutics AG
image
Current Assets 1.91 B
Cash & Short-Term Investments 1.69 B
Receivables 200 M
Other Current Assets 14.4 M
Non-Current Assets 321 M
Long-Term Investments 1.97 M
PP&E 306 M
Other Non-Current Assets 13.6 M
Current Liabilities 109 M
Accounts Payable 38.1 M
Short-Term Debt 31.2 M
Other Current Liabilities 39.4 M
Non-Current Liabilities 238 M
Long-Term Debt 223 M
Other Non-Current Liabilities 15 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014
ASSETS
Cash & Cash Equivalents 389.5 211.9 923.0 1 168.6 943.8 456.6 239.8 315.5 156.0 0.9
Short Term Investments 1 304.2 1 603.4 1 456.1 521.7 0 0 0 0 0 0
Receivables 200.0 0 0.3 0.1 99 K 88 K 2.6 3.2 0.3 0
Inventory 0 (11.2) 0 0 1 1 1 0 1 0
Other Current Assets 14.4 37.7 29.7 15.4 7.0 15.9 12.0 3.0 0.5 23 K
Total Current Assets 1 908.1 1 853.0 2 417.5 1 716.6 987.5 466.4 248.4 320.2 156.8 1.0
PP&E 305.9 320.6 312.0 93.0 72.8 18.5 18.9 21.0 1.3 0
Intangible Assets 16 K 71 K 0.1 0.2 0.2 0.3 0.3 0.4 0.5 0.5
Goodwill 0 0 0 0 0 0 0 0 0 0
Long Term Investments 2.0 53.1 16.9 16.8 5.0 3.2 3.2 3.1 0.7 0
Other Long Term Assets 13.6 16.3 22.2 18.1 6.1 3.8 3.8 3.3 0.8 50 K
Other Assets 0 0 0 0 0 0 0 0 0 0
Total Assets 2 229.6 2 243.1 2 751.9 1 828.0 1 066.8 489.0 271.3 345.0 159.4 1.5
LIABILITIES
Accounts Payable 38.1 27.4 14.8 9.1 5.9 5.1 1.6 4.6 1.6 0.2
Short Term Debt 31.2 31.7 24.3 22.7 17.0 0 0 0 0 0
Other Current Liabilities 34.9 61.9 79.0 49.6 32.6 22.3 12.5 17.4 8.5 1.9
Total Current Liabilities 108.8 121.1 119.9 94.3 57.1 27.7 14.5 22.0 10.2 2.1
Long Term Debt 223.0 228.2 212.9 50.1 44.0 0 0 0 (26.2) 0
Deferred Tax Income 0 0 0 0 0 0 0 0 64.5 0
Other Liabilities 1.0 6.0 7.3 7.6 14.4 11.3 12.1 12.5 (64.1) 6.4
Total Liabilities 346.8 367.6 352.4 163.7 127.3 96.8 83.5 112.1 188.5 8.5
EQUITY
Common Stock 2.5 2.4 2.4 2.3 1.8 1.6 1.2 1.2 0.2 0.1
Retained Earnings (999.7) (846.1) (195.9) (573.6) (224.7) (291.6) (125.4) (57.1) (33.9) (8.4)
Other Accumulative Comprehensive Income/Loss 1.9 (15.6) (5.1) 83 K 7 K 8 K 14 K 26 K 8 K 2 K
Total Equity 1 882.8 1 875.5 2 399.5 1 664.2 939.4 392.2 187.8 232.8 (29.1) (7.0)
Total Liabilities and Equity 2 229.6 2 243.1 2 751.9 1 828.0 1 066.8 489.0 271.3 345.0 159.4 1.5
SHARES OUTSTANDING
Common Shares Outstanding 79.2 77.7 75.9 65.9 54.4 48.0 40.0 12.3 29.3 29.3